{"title": "PDF", "author": "PDF", "url": "https://aci.health.nsw.gov.au/__data/assets/pdf_file/0003/640155/20210323-Daily-Evidence-Digest.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "cleaned_text": "Daily evidence digest 23 March 2021 Neutralising antibodies after infection and vaccination, l iving with children and the risk of COVID -19, vaccine second -dose completion in the US Peer reviewed journals featured: A narrative review on SARS -CoV-2 variants, immune responses and neutralisation -resistance here Modelling stud ies on: o SARS -CoV-2 vaccination alongside physical distancing in the UK here and associated commentary here o Vaccination and non -pharmaceutical interventions for COVID -19 in the UK here A case report on viable SARS -CoV-2,72 days after infection in an immunocompromised patient here Observational studies on: o COVID -19 vaccine second -dose completion and interval between first and second doses in the US here o An association between l iving with children and outcomes from COVID -19 here o An association between sharing a household with children and the risk of COVID -19 in healthcare worker households in Scotland here o A comparison of COVID -19 policies in aged care homes in Australia and the UK here o An association between vitamin D levels, race/eth nicity, clinical characteristics and COVID -19 test results here o Trends in mortality and length of stay among COVID -19 patients (April - July 2020) in the US here Letters and correspondence discussed: Neutralising antibodies against SARS -CoV-2 variants after infection and vaccination here A proposal for f ree licensing of vaccines to end the COVID -19 crisis here Safety of mRNA SARS -CoV-2 vaccines for patients with rheumatic musculoskeletal disease here Early antibody response in kidney transplant recipients after first dose of mRNA vaccin e here The daily evidence digest collates recently released reports and evidence - provision of these links does not imply endorsement nor recommendation. COVID -19 Critical Intelligence Unit 23 March 2021 The daily evidence digest collates recently released reports and evidence - provision of these links does not imply endorsement nor recommendation. Pre-peer review articles featured: The effect of vaccination on transmission of COVID -19 here The indirect health impacts of COVID -19 restrictions here Evidence for antibody as a protective correlate for COVID -19 vaccines here Information about COVID -19 vaccine effectiveness and its impact on behavioural intentions here The risk of reinfection after seroconversion to SARS -CoV-2 here Development and validation of tools to monitor post-acute COVID -19 syndrome here Long-term outcomes in COVID -19 patients associated with neurological complications here Guidance and reports The Organisation for Econo mic Cooperation and Development released a report on global access to COVID -19 vaccines here The Australian Techinc al Advisory Group on Immunisation (ATAGI) released a statement and clinical guidance on AstraZeneca COVID -19 vaccine safety here The Therapeutic Goods Administration (TGA) released updates on AstraZeneca vaccine here, here and here News and blogs Stronger warnings are needed to curb socialising af ter vaccination here Influenza vaccination in 2021 here Lateral flow tests and mass testing in schools in the UK here Sputnik V and other Russian vaccines here Protecting society from pandemics and politicians here Balancing monitoring for adverse events with confidence in vaccines here Increased risk of mortality in patients infected with B.1.1.7 (UK / Kent) variant here The medical establishment 'is failing the UK public ' on COVID -19 here Click here to subscribe to the daily evidence digest. "}